Technology scouting can be used to both discover opportunities and to more clearly understand the competitive landscape. In all instances, the process requires a deep understanding of demand; this is achieved through analysis and deconstruction of needs into functional requirements. The approach taken by Health Enterprise East (HEE) ensures a more comprehensive search and selection process to understand opportunities and / or mitigate threats. 

Case Study: Scouting for disruptive technologies over a 10 year timescale


A global medical device company wanted to identify potential disruptors to its core business over a 10 year timescale.

For this project, the team :
  • Reviewed eight care pathways representing the top business areas, including six cancers to identify unmet needs covering diagnosis, treatment and management of the diseases
  • Identified technologies which meet those needs from academic research through to commercially available products
  • Determined the impact and likelihood based on a range of criteria, including technology readiness, reliance on other technologies for commercialisation, business impact both individually and comparatively, to identify those opportunities least likely to be disrupted in the long term  

The project enabled the company to establish new relationships, collaborations and explore acquisitions and licensing opportunities.

The opportunities represented both those to bolster and protect its pipeline, as well as technologies of potential interest to other portfolio companies.

Case Study: Technology scouting for interventional oncology technologies


A large interventional radiology company wished to understand and enter the interventional oncology space.

To support the project, HEE:
  • Set screening, attractiveness and fit criteria in a client workshop and reviewed acceptable parameters of search approach
  • Identified technologies from academic research through to commercially available products via secondary research and speaking with KOLs from high profile cancer centres, including those that had designed and developed early technologies in this space
  • Applied screening criteria to long list and carried out research to be able to populate pertinent information regarding attractiveness and fit in order to score appropriately with client


The project identified and assessed the suitability of  interventional oncology technologies across a broad spectrum, giving a range of options for a current and future portfolio.

Case Study: Technology scouting for novel and alternative diagnostic technologies


A global diagnostics company was conducting a review of its 10 year pipeline and wanted HEE to consider ‘any/all’ technologies not directly within the diagnostics space, that could be applied at a technical, workflow, consumables etc. level, to identify opportunities to strengthen and differentiate its pipeline.

For this project HEE:
  • Set search and screening criteria in a client workshop
  • Reviewed a wide range of industries/technologies/ideas from academic research through to commercially available products
  • Carried out both primary and secondary research into the technologies/products in order to assess where within diagnostics it could impact, the attractiveness to the market by validating the unmet need and the extent to which the solution fulfilled it
  • Held a workshop to review and determine the fit to the client portfolio  and shortlisted ‘top’ opportunitie

The project gave the client a well-researched and reviewed shortlist of opportunities to consider introducing into its portfolio.


Identification of technologies for a new ophthalmology business franchise


The investment arm of a global medical corporation wanted to identify technologies for inclusion in a new $multimillion ophthalmology franchise.
  • We worked collaboratively with the client to identify the most significant areas of opportunity, through care pathway analysis to understand current standards; unmet needs were explored with key opinion leaders and technology experts
  • With a focus on glaucoma and age-related macular degeneration, we carried out a comprehensive technology scout for prospects across the care pathway, looking at opportunities in very early stage development through to existing products before ranking, scoring and assessing the list for impact and likelihood

The project delivered a balanced portfolio of transactable opportunities for the company to pursue.